aTYR PHARMA INC
ATYR· Nasdaq
Filed May 11, 2016 · 10-Q · 41 days after period end · 0001564590-16-019103
| Metric | Q1 2016 | Q1 2015 | Q1 2014 |
|---|---|---|---|
| Net Income | -$16.09M | -$9.07M | -$6.09M |
| EPS Diluted | -$0.68 | -$9.39 | -$7.87 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
aTYR PHARMA INC · CIK 1339970 · Engraved from SEC EDGAR
ended Mar 31, 2016 · filed May 11, 2016 · 41 d after period end